THREE NOVEL CANDIDATES AS MU OPIOID RECEPTOR ANTAGONISTS: AN IN SILICO STUDY

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 383

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

KAMED13_334

تاریخ نمایه سازی: 10 دی 1398

Abstract:

Background and Aim : Morphine analgesic overdose is a lethal condition that is reversible by administration of mu opioid antagonists like naloxone. This treatment can be associated with side effects. In this study, we aimed to design novel chemical compounds as potential mu opioid receptor (MOR) antagonists. Methods : We used Chemdraw, Hyperchem and Autodock Tools soft wares to design, optimize and dock these compounds to the receptor. We designed 11 chemical compounds that three of them were successfully docked. None of these compounds were found in Google Scholar, Google search engine and other databases. Exclusion criteria included unsolved non-integral charge, half electron approximation in geometry with minimum energy, non-bonded atoms and optimization errors. Results : The obtained results of the molecular docking simulation using the mu opioid receptor (PDB code: 4DKL) showed the lowest binding energies (LBEs) and estimated Inhibition constants (KIs). Three novel compounds including a 8-Carboxamidocyclazocine analogue (LBE= -8.99 kcal/mol, Ki=256.85 nM) and two triazole derivatives (LBE= -9.21 kcal/mol, Ki=178.45 nM and LBE= -8.66 kcal/mol, Ki=445.88 nM) were suitably fitted in the active site of MOR in comparison with the main ligand (LBE=-10.13 kcal/mol, Ki=37.78 nM) in MOR. In parallel, LBEs and KIs of these compounds and standard antagonist naloxone (LBE=-8.21 kcal/mol, Ki=960.18 nM) in temperature of 298.15 K were compared. Conclusion : As a conclusion, all of three novel compounds had better potential antagonist properties than standard antagonist naloxone. The best antagonist candidate among them was 7-amino-3-(cyclopropylmethyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocine-8-carboxamide. We suggest further In Silico, synthetic, In Vitro, In Vivo and behavioral studies to evaluate selectivity of these compounds to the MOR, their brain penetration, efficacy and safety as potential therapeutic drugs and antidotes in morphine overdose. Key Message: Previous morphine overdose treatments with mu opioid receptor (MOR) antagonists associated with side effects. We designed three novel compounds as MOR antagonists with greater efficacies than naloxone.

Authors

Maysam Fadaei-kenarsary

Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, I.R.Iran

Alieh Ameri

Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, I.R.Iran